Clinical Trials List
Protocol NumberOEP-6CR003-401
2018-03-15 - 2020-12-18
Phase IV
Recruiting1
-
Trial Applicant
Orient EuroPharma Co., Ltd.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- 彭莉甯 Division of Geriatrics
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
80 participants